Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Preferred Stock Liabilities (2020 - 2021)

Core Scientific's Preferred Stock Liabilities history spans 2 years, with the latest figure at $44.5 million for Q4 2021.

  • For Q4 2021, Preferred Stock Liabilities changed 0.0% year-over-year to $44.5 million; the TTM value through Dec 2021 reached $44.5 million, changed 0.0%, while the annual FY2021 figure was $44.5 million, 0.0% changed from the prior year.
  • Preferred Stock Liabilities for Q4 2021 was $44.5 million at Core Scientific, down from $345.0 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $345.0 million in Q3 2021 and bottomed at $44.5 million in Q4 2020.